Skip to main content

Mireia Armengol Alsina

Institutions of which they are part

Postdoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Mireia Armengol Alsina

Mireia Armengol Alsina

Mireia Armengol Alsina

Institutions of which they are part

Postdoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Programa para ejercer actividad investigadora y asistencial en Medicina Materno-Fetal

IP: Elena Carreras Moratonas
Collaborators: Mireia Armengol Alsina, Miriam Izquierdo Sans, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM23/00017
Duration: 08/01/2024 - 07/01/2026

Manejo de los fetos con retraso de crecimiento intrauterino precoz: Factores angiogénicos versus Doppler feto-materno (early GRAFD Trial).

IP: Manel Mendoza Cobaleda
Collaborators: Mireia Armengol Alsina, Pablo García Manau, Erika Bonacina
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI22/00051
Duration: 01/01/2023 - 31/12/2025

Recerca biomèdica en ginecologia

IP: Antonio Gil Moreno
Collaborators: Natalia Rodriguez Gómez - Hidalgo, Elena Suarez Salvador, Jose Luis Poza Barrasus, Vicente Bebia Conesa, Angel García Jiménez, Maria Asuncion Perez Benavente, Carina Masferrer Ferragutcasas, Eva Colas Ortega, Sabina Salicrú Riera, Anna Ruano Lopez, Fco Javier De la Torre Fdez de Vega, Montserrat Cubo Abert, Silvia Cabrera Diaz, Laura Mañalich Barrachina, Marta Rebull Santamaria, Mireia Armengol Alsina, Ana Luzarraga Aznar, Irene De la Calle Fuentes, José Luis Sánchez Iglesias, Melissa Bradbury Lobato, Beatriz Villafranca Magdalena, Melek Denizli, Paula Cabre Fernandez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01157
Duration: 01/01/2022 - 30/06/2025

Cribado de preeclampsia en la gestación gemelar

IP: Carlota Rodó Rodríguez
Collaborators: Pablo García Manau, Berta Serrano Sanchez, Francisco Barranco Martinez, Mireia Armengol Alsina
Funding agency: Instituto de Salud Carlos III
Funding: 162140
Reference: PI21/00601
Duration: 01/01/2022 - 31/12/2024

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Julia Basallote Garcia deQuiros

Julia Basallote Garcia deQuiros

Tècnic/a Grau Superior
National Projects Unit
Competitive Projects Area
Read more
Aina Marti Carretero

Aina Marti Carretero

Predoctoral researcher
Liver Diseases
Read more
Ana Alvarez Guaita

Ana Alvarez Guaita

Postdoctoral researcher
Diabetes and Metabolism
Read more
Marta Vicenta Arjona Perís

Marta Vicenta Arjona Perís

Predoctoral researcher
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.